Cargando…
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics are in high demand, and for this reason antimicrobial peptides (AMPs) have attracted consid...
Autores principales: | Molchanova, Natalia, Hansen, Paul R., Franzyk, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151827/ https://www.ncbi.nlm.nih.gov/pubmed/28850098 http://dx.doi.org/10.3390/molecules22091430 |
Ejemplares similares
-
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
por: Molchanova, Natalia, et al.
Publicado: (2019) -
Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization
por: Andrea, Athina, et al.
Publicado: (2018) -
Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015) -
Macrolide Resistance and In Vitro Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli
por: Ma, Yibing, et al.
Publicado: (2022) -
Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)